Vedolizumab-Associated Drug-Induced Liver Injury: A Case Series

被引：7

作者：

Honap, Sailish ^{[1
,2
]}

Sticova, Eva ^{[3
]}

Theocharidou, Eleni ^{[4
]}

Berry, Philip ^{[4
]}

Irving, Peter M. ^{[1
,2
]}

Samaan, Mark A. ^{[1
]}

Kotha, Sreelakshmi ^{[4
]}

机构：

[1] Guys & St Thomas NHS Fdn Trust, IBD Ctr, London, England

[2] Kings Coll London, Sch Immunol & Microbial Sci, London, England

[3] Kings Coll London, Inst Liver Studies, London, England

[4] Guys & St Thomas NHS Fdn Trust, Dept Hepatol, London, England

来源：

INFLAMMATORY BOWEL DISEASES | 2021年 / 27卷 / 03期

关键词：

vedolizumab; drug-induced liver injury; hepatitis; cholestasis;

D O I：

10.1093/ibd/izaa286

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：E32 / E34

页数：3

共 5 条

[1]

[Anonymous], 2012, LIVERTOX CLIN RES IN

[2] The safety of vedolizumab for ulcerative colitis and Crohn's disease [J].

Colombel, Jean-Frederic ;

Sands, Bruce E. ;

Rutgeerts, Paul ;

Sandborn, William ;

Danese, Silvio ;

D'Haens, Geert ;

Panaccione, Remo ;

Loftus, Edward V., Jr. ;

Sankoh, Serap ;

Fox, Irving ;

Parikh, Asit ;

Milch, Catherine ;

Abhyankar, Brihad ;

Feagan, Brian G. .

GUT, 2017, 66 (05) :839-851

[3] Vedolizumab in IBD/PSC: A Case for Careful Vigilance? [J].

Jones, F. ;

Doherty, G. A. .

JOURNAL OF CROHNS & COLITIS, 2019, 13 (10) :1237-1238

[4]

Lisle J, 2019, J CROHNS COLITIS, V13, pS403

[5] Chronic Cholestatic Liver Injury Attributable to Vedolizumab [J].

Stine, Jonathan G. ;

Wang, Jennifer ;

Behm, Brian W. .

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2016, 4 (03) :277-280

← 1 →